
Considerations for investing in whisky
Richard Grimster, Head of Tax at Price Bailey discusses the main considerations for investing in whisky with Andrew Nelstrop, Managing Director of The English Whisky Co.
With a strong presence in Cambridge and offices based across London, the East of England, and internationally, pharmaceutical companies are a core sector for Price Bailey, with clients spanning all areas of the supply chain.
To support pharmaceutical companies, we have crafted our service offering to ensure that we can support you at whichever stage of your business lifecycle you find yourself.
The last couple of years has contained some of the greatest global challenges we have ever seen for numerous businesses, including pharmaceutical companies.
As a result, pharmaceutical companies have seen a rapid increase in demand to manufacture and deliver drugs to a market at an unprecedented speed. This, combined with regulatory changes, supply chain and skilled labour shortages around the world, has had a significant impact on pharmaceutical companies.
The speed at which pharmaceuticals can be brought to market is causing many to review their resources, operations, and strategies to prevent possible delays in their supply chains.
To alleviate some of the pressures that pharmaceutical companies may be facing and to allow you more headspace to focus on advancing your business, we can offer an extensive range of expert accountancy services.
Contact us today to find out more about how we can help you
Richard Grimster, Head of Tax at Price Bailey discusses the main considerations for investing in whisky with Andrew Nelstrop, Managing Director of The English Whisky Co.
The Humane League UK partnered with Price Bailey in 2025. They wanted a partner who could provide guidance and support as they grew.
The Employment Rights Bill will introduce significant changes to Statutory Sick Pay (SSP) from April 2026. Read more here...
In our series of VAT Myths, we debunk some of the most common VAT myths once and for all.